Beheshti Afshin, Neuberg Donna, McDonald J Tyson, Vanderburg Charles R, Evens Andrew M
Division of Hematology/Oncology, Molecular Oncology Research Institute, Tufts Medical Center, Boston, MA, USA.
Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard University, Boston, MA, USA.
Cancer Inform. 2015 Dec 10;14:141-8. doi: 10.4137/CIN.S34144. eCollection 2015.
Potential molecular alterations based on age and sex are not well defined in diffuse large B-cell lymphoma (DLBCL). We examined global transcriptome DLBCL data from The Cancer Genome Atlas (TCGA) via a systems biology approach to determine the molecular differences associated with age and sex. Collectively, sex and age revealed striking transcriptional differences with older age associated with decreased metabolism and telomere functions and female sex was associated with decreased interferon signaling, transcription, cell cycle, and PD-1 signaling. We discovered that the key genes for most groups strongly regulated immune function activity. Furthermore, older females were predicted to have less DLBCL progression versus older males and young females. Finally, analyses in systems biology revealed that JUN and CYCS signaling were the most critical factors associated with tumor progression in older and male patients. We identified important molecular perturbations in DLBCL that were strongly associated with age and sex and were predicted to strongly influence tumor progression.
在弥漫性大B细胞淋巴瘤(DLBCL)中,基于年龄和性别的潜在分子改变尚未明确界定。我们通过系统生物学方法检查了来自癌症基因组图谱(TCGA)的DLBCL全局转录组数据,以确定与年龄和性别相关的分子差异。总体而言,性别和年龄显示出显著的转录差异,年龄较大与代谢和端粒功能降低相关,而女性与干扰素信号传导、转录、细胞周期和PD-1信号传导降低相关。我们发现,大多数组的关键基因强烈调节免疫功能活性。此外,预计老年女性的DLBCL进展比老年男性和年轻女性少。最后,系统生物学分析表明,JUN和CYCS信号是与老年和男性患者肿瘤进展相关的最关键因素。我们在DLBCL中发现了重要的分子扰动,这些扰动与年龄和性别密切相关,并预计会强烈影响肿瘤进展。